Edit |   |
---|---|
Antigenic Specificity | CD30, Human (Brentuximab biosimilar) |
Clone | Brentuximab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | Human IgG1 |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD30 Recombinant Antibody (Brentuximab). Brentuximab vedotin (INN, trade name Adcetris) is an antibody-drug conjugate medication used to treat relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (ALCL), a type of T cell non-Hodgkin lymphoma. It selectively targets tumor cells expressing the CD30 antigen, a defining marker of Hodgkin lymphoma and ALCL. |
Immunogen | n/a |
Other Names | Anti-CD30 Recombinant Antibody, Research Grade Brentuximab, Anti-Human CD30 Recombinant Antibody(Brentuximab), , Antibody Drug Analogues, Monoclonal Antibody, YR1614, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | n/a |
Catalog # | YR1614 |
Price | please inquire |
Order / More Info | CD30, Human (Brentuximab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |